This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CleanPath Resources Corp (OTC Pink: CLNP) Announced A Licensing Agreement With Hemp, Inc. (OTC Pink: HEMP) Giving CleanPath Access To The Agronifier™ Technology Used To Increase The Efficacy Of Nutraceuticals.

LAS VEGAS, July 17, 2013 /PRNewswire/ -- CleanPath Resources Corp (OTC Pink: CLNP) ( www.re-load.biz) announced today a licensing agreement with a subsidiary of Hemp, Inc. (OTC Pink: HEMP) for the patent pending process used to greatly increase the effectiveness of nutraceuticals and functional beverages.

The process was originally designed as a non-invasive way to treat pain and swelling in people. Surprisingly, it was later discovered that its acoustic and electromagnetic waves also enhanced the effects of the nutraceuticals and functional beverages while improving the flavor of food and drinks. This wide range of benefits of the technology offers many new opportunities to CleanPath.

Ken Lewis, CleanPath's CEO stated, "I have personally tested the results of this process and have been amazed with the results. This safe, non-invasive process is based upon research into a safe pain relieving device which amazingly also makes beverages taste better, including wine, and makes the nutraceuticals  and functional beverages more effective." Ken Lewis went on to say, "This will open up the path to many new unique products that we believe will be in high demand. From wine enhancing products to superior herbal remedies this technology will really help us grow."

Media contact: Ken Lewis, 1-877-309-9876, KenLewis@re-load.biz

SOURCE CleanPath Resources Corp

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs